B3 Consulting Group AB (publ) (STO:B3)
56.50
+2.20 (4.05%)
Aug 1, 2025, 5:29 PM CET
Akoya Biosciences Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.